Carbapenemase Gene Transmission in CREC, Guangdong
2026-09-07
Chen et al. combine gene localization, antimicrobial susceptibility testing, conjugation assays, mobile-element profiling, and ERIC-PCR typing to characterize carbapenem-resistant Enterobacter cloacae across eight teaching hospitals. The study identifies plasmid-associated blaNDM-1 as a major transferable resistance determinant and shows why molecular surveillance must distinguish horizontal gene transfer from clonal dissemination.
Caffeine: Applied Workflows for Cell and Metabolic Studies
2026-09-05
Caffeine supports reproducible dose-response studies in sarcoma models and targeted investigations of energy metabolism. This guide converts product specifications and reference-study lessons into practical workflows, combination screens, troubleshooting steps, and translationally cautious assay designs.
Temozolomide, Senescence, and Bcl-2 in Glioblastoma
2026-09-05
The reference study shows that temozolomide-treated glioblastoma cells can persist in a senescent state through increased c-IAP2 and Bcl-2 activity. Combining BV6 with venetoclax selectively increased death in these senescent cells, highlighting a potential senolytic strategy that complements—not simply repeats—temozolomide treatment.
Single-Cell Ciprofloxacin–Tetracycline Antagonism
2026-09-04
Broughton, Fraisse, and El Karoui used microfluidic single-cell analysis to explain why ciprofloxacin and tetracycline interact antagonistically. The combination improved growth primarily by increasing survival among ciprofloxacin-exposed cells, with nutrient-dependent growth rate and heterogeneous SOS responses determining the strength of suppression.
Urolithin A and Metabolic Assay Design
2026-09-04
Urolithin A research becomes more informative when mitochondrial quality control is interpreted alongside cellular metabolism. This guide connects mitophagy readouts with glutamine-dependent signaling, assay design, and model-specific limitations.
MRSA Research: Mechanisms, Epidemiology, and Methods
2026-09-03
Turner and colleagues integrate molecular, epidemiological, and clinical evidence to explain why methicillin-resistant Staphylococcus aureus remains a successful and difficult-to-treat pathogen. The review’s central contribution is its strain-aware framework, which connects mecA-mediated resistance, transmission ecology, epidemic clone replacement, and treatment decisions to the design of more informative Staphylococcus aureus infection research.
PreScission Protease (PSP): Tag Cleavage Guide
2026-09-03
PreScission Protease (PSP) is an HRV 3C protease fusion enzyme for removing affinity tags from recombinant fusion proteins at a defined Gln-Gly junction. It is suited to controlled protein purification workflows, but not to constructs lacking the specified recognition sequence or applications requiring nonspecific proteolysis.
HyperScribe T7 High Yield RNA Synthesis Kit Plus Workflow
2026-09-02
Build high-yield RNA for mRNA rescue, labeled-probe assays, antisense studies, and RNA interference experiments from a linearized DNA template. The HyperScribe™ T7 High Yield RNA Synthesis Kit Plus combines a pre-supplemented T7 enzyme mix with flexible nucleotide options and scalable reaction capacity for reproducible research workflows.
Antipyrine in BBB Permeability Workflows
2026-09-02
Antipyrine combines high aqueous solubility with a defined chemical identity, making it a practical comparator for permeability, pharmacokinetic, and drug metabolism research. This workflow shows how to integrate it into LLC-PK1-MOCK/MDR1 Transwell assays while avoiding misleading conclusions from barrier failure or lysosomal trapping.
In Vitro Drug Response: Beyond Relative Viability
2026-09-01
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability to separate growth inhibition from actual cell killing in cancer drug-response studies. Its central implication is practical: dose–response experiments should measure both response dimensions and consider their timing rather than treating a single viability value as a complete pharmacologic phenotype.
IEM 1460: From AMPA Blockade to Assay Design
2026-09-01
IEM 1460 is a selective AMPA receptor blocker for dissecting fast glutamatergic signaling, excitotoxicity, and neuroprotection. This article translates findings from a recent IEM-1925 seizure study into practical assay-design principles while clearly separating evidence from workflow hypotheses.
Resiquimod (R-848) in Immune Assays
2026-08-31
Resiquimod (R-848) provides a practical way to activate TLR7/8 and quantify innate immune response modulation in cell, hydrogel, and tumor-ablation workflows. This guide connects stock preparation and assay controls with a thermal-protective chemo-immunomodulation strategy demonstrated in a recent preclinical study.
Digestive Transformations of Withania somnifera
2026-08-30
This 2026 study combines simulated gastrointestinal digestion with LC–MS/MS metabolomics and molecular networking to determine how Withania somnifera leaf and root extracts change before absorption. The results distinguish labile constituents, including withaferin A and withanoside IV, from the comparatively stable withanolide A and root-extract withanolides, providing a more realistic framework for evaluating botanical bioavailability.
MEG3, NiO Nanoparticles, and Pulmonary Fibrosis
2026-08-29
The reference study identifies lncRNA MEG3 as a protective regulator in nickel oxide nanoparticle-induced pulmonary fibrosis and connects its loss to TGF-β1-dependent PI3K/AKT activation. Using rat and A549 cell models, the authors combine exposure experiments, pharmacologic inhibition, fibrosis markers, and MEG3 overexpression to define a mechanistic pathway relevant to nanotoxicology.
Nutlin-3a: MDM2 Inhibitor for p53 Research
2026-08-29
Nutlin-3a is a small-molecule MDM2 inhibitor that restores p53 signaling by blocking the MDM2 TP53-binding pocket. It is used in cancer research to study p53 pathway activation, cell cycle arrest, and apoptosis induction, with potency and handling parameters defined by product documentation and peer-reviewed pharmacology.
459 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page